NPR News: R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds

R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
Industry says it costs about $2.7 billion to bring a cancer drug to market. But oncologists who ran the numbers put the average closer to $650 million. Drugs are priced way too high, the doctors say.

Read more on NPR